14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
MWC vs LNAI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Lunai Bioworks Inc. (LNAI) is the stronger overall head-to-head candidate over MWC (MWC) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). MWC carries a Unified Composite Score of 44.7/100 (HOLD) at $1.20 (N/M Forward P/E, N/A operating margin), whereas LNAI carries 44.1/100 (HOLD) at $0.16 (N/M Forward P/E, -6888.6% operating margin).
Composite vs. Pillar Nuance: While MWC currently prints a higher short-term Unified Composite Score (44.7/100 HOLD vs. LNAI 44.1/100 HOLD), LNAI captures the overall institutional head-to-head verdict (5–3 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (-6888.6% vs. N/A operating margin) and revenue trajectory (+0.0% vs. N/A YoY).
Technical & Structure Timing Caution: MWC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.8); meanwhile LNAI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 13.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MWC vs LNAI. Trailing 12-month operating profitability (MWC N/A vs LNAI -6888.6%) and valuation multiples (MWC N/M vs LNAI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $1.2M market capitalization and -6888.6% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ MWC vs LNAI Key Questions & Quantitative Answers
As of Nov 20, 2026, Lunai Bioworks Inc. (LNAI) is the stronger overall head-to-head candidate over MWC (MWC) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). MWC carries a Unified Composite Score of 44.7/100 (HOLD) at $1.20 (N/M Forward P/E, N/A operating margin), whereas LNAI carries 44.1/100 (HOLD) at $0.16 (N/M Forward P/E, -6888.6% operating margin). Composite vs. Pillar Nuance: While MWC currently prints a higher short-term Unified Composite Score (44.7/100 HOLD vs. LNAI 44.1/100 HOLD), LNAI captures the overall institutional head-to-head verdict (5–3 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (-6888.6% vs. N/A operating margin) and revenue trajectory (+0.0% vs. N/A YoY). Technical & Structure Timing Caution: MWC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.8); meanwhile LNAI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 13.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
LNAI leads the Growth & Scale pillar: MWC posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with LNAI at +0.0% YoY revenue growth and +0.0% YoY earnings growth on $51,992 TTM revenue (100.0% gross margin, -6888.6% operating margin). On trailing 12-month operating scale, MWC generates N/A in USD-normalized revenue versus $51,992 for LNAI. In operating R&D and SG&A reinvestment, MWC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for LNAI.
MWC and LNAI trade at balanced relative valuation multiples. MWC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas LNAI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MWC (N/A ROE) versus LNAI (-325.5% ROE) capital efficiency.
In options market volatility and institutional positioning, MWC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.68β · 130% Vol realized risk). By comparison, LNAI carries 0.1% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.92β · 186% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.